MarkosWebWeb intelligence for the agentic economy

株式会社セルージョン

Active

Cellusion is a developer of corneal endothelial regenerative medicine intended to improve world visibility.

cellusion.jpAI readiness report

What it does

"Cellusion is a pioneering medtech company focused on developing corneal endothelial regenerative medicine to enhance global visibility in the Japanese healthcare industry. With a vision to contribute to the advancement of next-generation regenerative medicine, Cellusion aims to address three key challenges in traditional corneal transplant treatments. By mass-producing corneal endothelial cells from iPS cells and utilizing cell injection therapy for transplantation, Cellusion simplifies and shortens surgical procedures. This innovative approach reduces invasiveness compared to conventional transplant treatments, alleviating patient burden. By utilizing allogeneic iPS cells, Cellusion eliminates the need for eye banks and facilitates easy access to pharmaceutical products for patients. Through these advancements, Cellusion offers innovative solutions in regenerative medicine to enhance the quality of life for patients worldwide."

Its site says now · captured 2026-08-23

CELLUSION | CELLUSION – ひとの可能性を再生する。

ひとの可能性を再生する。

Next to it in Healthcare and bio · corneal endothelial regenerative medicine

  • 株式会社ヘリオスPlug and Play

    Healios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.

  • 株式会社マトリクソームPlug and Play

    Matricome develops regenerative medicines by disseminating laminin E8 fragment technology.

  • Rege NephroPlug and Play

    Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.

  • HepatxY Combinator S18

    Replacing organ transplant with an infusion

  • Cell Factor Inc.Plug and Play

    Renewal medicine 3 elements +1 authentic society implementation -from postcolona, ​​from intractable diseases to pre -empty medical care. / 再生医療3要素 +1の本格社会実装 ～ポストコロナ、難病から先制医療まで～

  • iHeart JapanPlug and Play

    iHeart Japan is developing regenerative medicinal products for severe heart failure, using iPSC technologies.

  • 株式会社メトセラPlug and Play

    Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

  • マイキャン・テクノロジーズ株式会社Plug and Play

    MiCAN Technologies medical and nursing Care company.